ST. PAUL, Minn.--(BUSINESS WIRE)--According to the latest data in a clinical study supported by St. Jude Medical, Inc. (NYSE:STJ), deep brain stimulation (DBS) therapy for depression may provide sustainable improvement in depression symptoms among patients with major depressive disorder. Study results will be presented today at the American Psychiatric Association (APA) meeting in San Francisco.
